Vergoeding 2019-2023 voor ATC-subgroep B01AF : Directe remmers van factor xa
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| B01AF01 Rivaroxaban (Xarelto ®) | 79.582.800 | 91.690.000 | 100.546.900 | 112.237.800 | 126.379.700 |
| B01AF02 Apixaban (Eliquis ®) | 61.322.600 | 77.029.200 | 93.343.000 | 113.775.000 | 121.620.900 |
| B01AF03 Edoxaban (Lixiana ®) | 17.800.500 | 23.635.300 | 27.756.200 | 32.297.000 | 38.995.500 |
| Totaal | 158.705.900 | 192.354.500 | 221.646.100 | 258.309.800 | 286.996.100 |